CASI Pharmaceuticals, Inc. (36) | Stock Agreements (4)
Recent Contracts
-
Common Stock Sales Agreement (the Sales Agreement) by and between CASI Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC dated October 29, 2021
(Filed With SEC on October 29, 2021)
-
Description of Common Stock
(Filed With SEC on March 30, 2021)
-
Description of Common Stock
(Filed With SEC on March 16, 2020)
-
Amendment No. 1 to Common Stock Sales Agreement by and between CASI Pharmaceuticals, Inc. and H.C. Wainwright & Co., LLC dated July 19, 2019
(Filed With SEC on July 19, 2019)
